Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor Dormancy: Biologic and Therapeutic Implications. | World J Oncol | 2022 | 35317328 | PubTator, text mining | PubMed |
| The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges. | Front Oncol | 2022 | 35311091 | PubTator, text mining | PubMed |
| Inhibition of Axl Promotes the Therapeutic Effect of Targeted Inhibition of the PI3K/Akt Pathway in NRAS Mutant Melanoma Cells. | J Oncol | 2022 | 35310910 | PubTator, text mining | PubMed |
| Prognostic Value of Genomic Instability of m6A-Related lncRNAs in Lung Adenocarcinoma. | Front Cell Dev Biol | 2022 | 35309906 | PubTator, text mining | PubMed |
| Host Molecules Regulating Neural Invasion of Zika Virus and Drug Repurposing Strategy. | Front Microbiol | 2022 | 35308394 | PubTator, text mining | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
| Mechanisms of immune regulation by the placenta: Role of type I interferon and interferon-stimulated genes signaling during pregnancy. | Immunol Rev | 2022 | 35306673 | PubTator, text mining | PubMed |
| Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. | Mol Cancer | 2022 | 35303879 | PubTator, text mining | PubMed |
| Evaluation of Platelet-Rich Plasma Therapy for Peripheral Nerve Regeneration: A Critical Review of Literature. | Front Bioeng Biotechnol | 2022 | 35299637 | PubTator, text mining | PubMed |
| Intermittent treatment of BRAFV600E melanoma cells delays resistance by adaptive resensitization to drug rechallenge. | Proc Natl Acad Sci U S A | 2022 | 35290123 | PubTator, text mining | PubMed |
| Airway secretory cell fate conversion via YAP-mTORC1-dependent essential amino acid metabolism. | EMBO J | 2022 | 35285539 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer. | Int J Mol Sci | 2022 | 35269922 | PubTator, text mining | PubMed |
| The suppressive effects of Mer inhibition on inflammatory responses in the pathogenesis of LPS-induced ALI/ARDS. | Sci Signal | 2022 | 35258998 | PubTator, text mining | PubMed |
| GAS6-mediated dialogue between decidual stromal cells and macrophages is essential for early pregnancy maintenance by inducing M2-like polarization and cell proliferation of decidual macrophages. | Mol Hum Reprod | 2022 | 35258594 | PubTator, text mining | PubMed |
| Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators. | JHEP Rep | 2022 | 35252828 | PubTator, text mining | PubMed |
| Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancer. | J Bone Oncol | 2022 | 35251924 | PubTator, text mining | PubMed |
| Insights Gained and Future Outlook From scRNAseq Studies in Autoimmune Rheumatic Diseases. | Front Immunol | 2022 | 35251048 | PubTator, text mining | PubMed |
| Identification of a Novel Immune-Related lncRNA CTD-2288O8.1 Regulating Cisplatin Resistance in Ovarian Cancer Based on Integrated Analysis. | Front Genet | 2022 | 35237300 | PubTator, text mining | PubMed |
| The mechanisms of mutual relationship between malignant hematologic cells and mesenchymal stem cells: Does it contradict the nursing role of mesenchymal stem cells? | Cell Commun Signal | 2022 | 35236376 | PubTator, text mining | PubMed |
| ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression. | J Neuroinflammation | 2022 | 35227277 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=53